verified
SJR 0,108 · Q4
•
database
Scopus / SJR & DOAJ indexed
China
workspace_premium
Q4 — Pharmacology
lock
Subscription · DOAJ
Chinese Journal of Cancer Biotherapy
Chinese Journal of Cancer Biotherapy is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 5. It has an SJR impact factor of 0,108 and it has a best quartile of Q4. It has an SJR impact factor of 0,108.
ISSN: 1007-385X
Category: Pharmacology
Indexation:
verifiedScopus / SJR
verifiedDOAJ
open_in_new Portal NPD
menu_book Guidelines NPD
schedule
CountryOfPapers database fields
SJR Impact Factor
trending_up
0,108
Q4
H-index
5
Acceptance rate
pie_chart
63%
Source
Acceptance_Rate
Time to publication
hourglass_top
NPD
Field
NPD
Publication cost (APC)
payments
NPD
Subscription
Non-OA path
NPD
Metrics
Scimago and CountryOfPapers database fields
Scopus / SJR
DOAJ
SJR Impact
0,108
H-index
5
Docs (year)
114
Docs 3y
389
Total refs
4188
Cites 3y
33
Citable 3y
389
Cites/Doc 2y
0.11
Ref/Doc
36.74
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
shield
Researcher voice
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Fair & fast peer review
Clear APC / no surprise fees
Suspected predatory
Fake impact claims
Researcher reviews
sentiment_dissatisfied
No reviews yet — be the first to share an honest experience.